Drugs / CSL-111
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00225719 | Jul 2005 → ? | acute coronary syndrome | CSL Limited | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL-111 | “111 to receive 40 mg/kg of reconstituted HDL (CSL-111)” PMID 17387133 ↗ Mar 2007 |